Australia's First
SEMAX
Nasal Spray



What is Semax?

Semax is a synthetic peptide analogue derived from a fragment of adrenocorticotropic hormone (ACTH). It is studied for its role in neurological signalling and pathways associated with cognitive function and brain activity.

Rather than acting as a stimulant, Semax is generally described as a neuromodulatory peptide, meaning it is associated with how signalling pathways in the brain are regulated and coordinated.

Because it interacts with multiple neurological pathways, Semax is typically considered in the context of system-wide cognitive signalling rather than isolated or immediate effects.

In Australia, Semax is not a registered therapeutic good. Where supplied, it is compounded by a pharmacy following consultation and assessment.

What Semax is Being Studied For?

Research involving Semax has explored its role within neurological and cognitive signalling systems.

Areas of investigation include:
- cognitive function and mental clarity
- attention and focus pathways
- neurotrophic signalling (including BDNF-related activity)
- response to cognitive and environmental stress
- neuroprotection in experimental models
- investigation within neurological research settings, including brain injury and cerebrovascular models

Much of this research focuses on how brain signalling is regulated and maintained under varying conditions, rather than targeting a single outcome.

Available evidence includes pre-clinical research and selected clinical studies in specific contexts. Broader applications remain under investigation, and use outside studied settings requires clinical judgement.

How It’s Dispensed?

Where supplied, Semax is compounded by an Australian pharmacy and dispensed in a nasal spray format.
Concentration: 0.1%
Total Volume: 6 mL
Total Content: 0.1% → 6 mg Semax per bottle
Delivery: Metered nasal spray (~0.1 mL per actuation)
Format: Multi-dose nasal spray bottle

Products are prepared in accordance with pharmacy compounding standards, with sterility and stability managed within controlled environments.

Storage & Handling

Store under refrigeration (2–8 °C) as directed by the dispensing pharmacy.
Do not freeze or expose to excessive heat
Protect from light
If ice packs soften during transit, this does not necessarily affect product integrity provided validated transport conditions are maintained
Follow all storage and handling instructions supplied.

Usage & Administration

Administration is determined based on individual context and guidance provided at supply.

Typical structured use may include:
Route: Intranasal
Dose: 1–2 sprays per nostril
Frequency: Once or twice daily
Timing: Morning or early in the day
Use: Consistent, short-term structured use

Administration should only occur following appropriate instruction.
Do not exceed recommended use unless directed.

Safety & Precautions

Semax should be used with appropriate screening and oversight.
Prior to use, all relevant medical history, medications, and supplements should be disclosed.
Additional consideration may be required in individuals with:
- neurological conditions
- psychiatric conditions
- sensitivity to intranasal products

Use is not recommended during pregnancy or breastfeeding.

Any unexpected symptoms or reactions should be reported to a healthcare professional or pharmacist.

Research Context

Semax remains an active area of investigation within neuroscience research.
It has been studied in controlled settings, including cognitive and neurological models. Levels of evidence vary depending on the context.
While international use exists within certain frameworks, Semax is not broadly approved for general therapeutic use in Australia.
Further research is required to establish long-term safety, optimal dosing strategies, and consistent outcomes.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice.
Semax is not a registered therapeutic good with the Therapeutic Goods Administration (TGA). Where supplied, it is compounded by a pharmacy following individual assessment.
No therapeutic claims are made.
Use only following appropriate consultation.

Mobile IV Drip

Selank Australia

Prescription Selank Australia

Australian Compounded Selank

Selank Nasal Spray

ExclusIV Disclaimer

By continuing, you acknowledge and agree to the following terms and conditions of ExclusIV by Mobile IV Drip:

1. Elective Wellness Services
All IV infusions and subcutaneous products offered through Mobile IV Drip are elective wellness services. They are not prescribed or promoted as medically necessary treatments and are designed to support general wellness and vitality.

2. No Public Advertising
The information displayed in this section is provided privately on request and does not constitute public advertising.

3. No Medical or Therapeutic Claims
No statements here should be interpreted as claims of therapeutic benefit. Services and compounded formulations are not a substitute for professional medical advice, prescribed medication, or conventional treatment.

4. Practitioner Review Required
Before any compounded or prescription-only product is supplied, clients are required to complete medical intake and be reviewed by an authorised prescriber and/or nurse practitioner, and obtain a prescription where required.

5. Pricing
Pricing shown is indicative only and may change following clinical assessment, prescription requirements, or compounding variables. Final costs are confirmed after prescriber approval.

6. Voluntary Request
You confirm you are voluntarily requesting this information for personal education, and that access does not guarantee suitability for every option listed.

7. Privacy
Any information you provide may be used to communicate about consultations, prescriptions or updates, with opt-out available.

By selecting “I want ExclusIV access”, you confirm you have read and understood the above.